Literature DB >> 1109793

Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma.

J M Yuhas, R E Toya, E Wagner.   

Abstract

The effects of specific dead tumor cell immunization and nonspecific immunostimulation with Corynebacterium parvum on the s.c. growth of the line 1 carcinoma in syngeneic BALB/c mice have been studied. Injection of heavily irradiated line ) carcinoma cells did not inhibit the transplantability or growth of the line 1 carcinoma, and in certain cases these treatments actually prolonged the period of rapid growth. This latter observation was traced to a mild inhibition of metastatic spread, which itself can slow the s.c. tumor growth. Treatment of the mice with 0.25 mg of C. parvum 7 days prior to transplant of the tumor had no effect on its growth by itself; but in combination with i.v.-injected tumor cells, which themselves had no effect on tumor growth, a 45% inhibition of tumor growth was induced. These data demonstrate that, in the weekly immunogenic line 1 carcinoma system, inhibition of s.c. transplants requires not only exposure to tumor antigens but also stimulation of the immunological reactivity.

Entities:  

Mesh:

Year:  1975        PMID: 1109793

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Nicotine promotes tumor growth and metastasis in mouse models of lung cancer.

Authors:  Rebecca Davis; Wasia Rizwani; Sarmistha Banerjee; Michelle Kovacs; Eric Haura; Domenico Coppola; Srikumar Chellappan
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

2.  Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo.

Authors:  S M Dubinett; L Patrone; J Tobias; A J Cochran; D R Wen; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.

Authors:  D W Bahler; J G Frelinger; L W Harwell; E M Lord
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice.

Authors:  T Kataoka; F Oh-hashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Characterization of a monoclonal antibody reactive with a glycolipid antigen expressed by tumorigenic and certain immortalized, non-tumorigenic rat esophageal epithelial cell lines.

Authors:  X Wan; R J Jamasbi; G D Stoner
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

6.  Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.

Authors:  S J Kennel; R Boll; M Stabin; H M Schuller; S Mirzadeh
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression.

Authors:  Lora C Bailey-Downs; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Paul J Hauser; Taleah Farasyn; William L Berry; Robert E Hurst; Michael A Ihnat
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.